What's in Universidade Federal de Goias's pipeline?

Universidade Federal de Goias has 8 drugs in our index: 4 marketed, 0 filed, 0 in Phase 3, 4 in Phase 2, 0 in Phase 1.

Which companies overlap with Universidade Federal de Goias's portfolio?

Top competitors by shared drug class: NYU Langone Health, Tel-Aviv Sourasky Medical Center, Aduro Biotech, Inc., Aga Khan University, Aimei Vacin BioPharm (Zhejiang) Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/universidade-federal-de-goias.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Universidade Federal de Goias — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Universidade Federal de Goias pipeline: 4 marketed, 0 filed, 0 Phase 3, 4 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

4 marketed 0 filed 0 Phase 3 4 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Reinforced vaccination schedule	Reinforced vaccination schedule	marketed	vaccine		Immunology
Midazolam, ketamine	Midazolam, ketamine	marketed	Benzodiazepine + NMDA receptor antagonist combination	GABA-A receptor (midazolam); NMDA glutamate receptor (ketamine)	Anesthesia / Sedation
Standard vaccination schedule	Standard vaccination schedule	marketed	vaccine		Immunology
Oral ketamine	Oral ketamine	marketed	NMDA receptor antagonist	NMDA receptor	Psychiatry, Pain Management, Anesthesia

Therapeutic area mix

Immunology · 2
Anesthesia / Sedation · 1
Psychiatry, Pain Management, Anesthesia · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

NYU Langone Health · 2 shared drug classes
Tel-Aviv Sourasky Medical Center · 2 shared drug classes
Aduro Biotech, Inc. · 1 shared drug class
Aga Khan University · 1 shared drug class
Aimei Vacin BioPharm (Zhejiang) Co., Ltd. · 1 shared drug class
Ajou University School of Medicine · 1 shared drug class
Alameda Health System · 1 shared drug class
Aeras · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Universidade Federal de Goias:

Cite this brief

Drug Landscape (2026). Universidade Federal de Goias — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/universidade-federal-de-goias. Accessed 2026-05-17.